TRIPS: balancing privacy and public welfare on the international stage Online publication date: Thu, 31-Jul-2014
by Laurel Parker
International Journal of Liability and Scientific Enquiry (IJLSE), Vol. 5, No. 3/4, 2012
Abstract: In intellectual property law, the agreement on trade-related aspects of intellectual property rights (TRIPS) has become the ultimate tool for international enforcement. However, this product of the WTO is far from perfect. This article focuses on TRIPS' patent provisions and the effect its restrictiveness has on developing countries as they struggle with populations with HIV/AIDS. An analysis of these issues show that TRIPS provisions placed on countries as they transition into the WTO, like length of patent rights and strict copyright laws, prevent them from: obtaining generic versions of drugs, legally adhering to the requirements of the WTO, and competing economically with more developed member states. As long as medications fall under patent protections, TRIPS will continue to be important force in intellectual property law. This article serves to illustrate the need of TRIPS adapt to the concerns of developed countries as well as the needs of the developing.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Liability and Scientific Enquiry (IJLSE):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook